Navigation Links
Ohio Bioscience Industry Leads Midwest, Among Best in Nation as Investment Destination
Date:10/21/2009

COLUMBUS, Ohio, Oct. 21 /PRNewswire/ -- While other states jockeyed for position on Business Facilities Magazine's second-annual Biotechnology Strength Report, Ohio defended its ranking as best in the Midwest and No. 4 in the nation for its strengths in the bioscience industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071107/CLW113LOGO )

Ohio's exceptional bioscience ranking is in part due to updated estimates of overall biotechnologies economic impact, incentives, academic research expansion, major new initiatives, growth potential and employment numbers. According to the Ohio Business Development Coalition, the nonprofit organization that markets the state for capital investment, the biotechnologies report further validates Ohio's standing as a national leader in the bioscience industry.

"Ohio Third Frontier project investments in innovation and technology, especially in the biosciences, really have catalyzed growth in both public and private sectors of our state's emerging industries," said BioOhio president and chief executive officer Tony Dennis, leader of the state's biotechnologies accelerator non-profit. "According to BioOhio's most recent Ohio Bioscience Growth Report, public and private investment has contributed to more than 1,100 bioscience organizations operating in our state, with an average of 70 new companies starting operations each year from 2004 to 2008."

The biotechnologies report's authors conclude that "the still-hot biotech sector has cemented its status as a crucial building block for future growth."

"That is certainly true in the State of Ohio," Dennis said.

According to Ed Burghard, executive director of the Ohio Business Development Coalition, Ohio's strength across all biotechnologies sectors - represented by the Red (health), Green (agriculture) and White (industrial) color model established by European biotechnologies leaders - is a leading reason behind its national performance in the bioscience industry. "Coupled with our state's other outstanding assets, business leaders are realizing how, in Ohio, they're able to find a perfect balance between successfully growing a business and still enjoying life," Burghard said. "Business owners profit from the bottom-line benefits of better work-life balance for their employees in low-cost, low stress communities in a combination of micropolitan and metropolitan. cities. Ohio truly is the state of perfect balance."

About the Ohio Business Development Coalition

The Ohio Business Development Coalition is a nonprofit organization that provides marketing strategy and implementation to support Ohio's economic development efforts. For more information, visit www.ohiomeansbusiness.com.

SOURCE Ohio Business Development Coalition


'/>"/>
SOURCE Ohio Business Development Coalition
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. OriGene Technologies Acquires Marligen Biosciences
2. Kansas Bioscience Authority Commits $50 Million to Increase Venture Capital, Accelerate Bioscience Business Growth
3. Cytopia Merger with Toronto-based YM BioSciences Inc.
4. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
5. Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009
6. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
7. Neurocrine Biosciences Amends Corporate Headquarters Lease
8. Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
9. Ohio Executive Shares Why Ohio is the Perfect Location for Bioscience Business in National Ad Campaign
10. EUCODIS Bioscience Launches Lipase Portfolio
11. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):